Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of Clinical and Translational Science
|
September 29, 2023
Evaluation of an online research best practices training for community health workers and promotoras
Susan L Murphy, Gina M Jay, Elias M Samuels, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 23, 2008
2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitor
John I Trujillo, James R Kiefer, Wei Huang, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2023
Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonists
Mark E Schnute, John I Trujillo, Katherine L Lee, et al.
Journal of Medicinal Chemistry
|
November 14, 2018
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors
Agustin Casimiro-Garcia, John I Trujillo, Felix Vajdos, et al.
Journal of Medicinal Chemistry
|
February 17, 2025
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists
Brian S Gerstenberger, Ray Unwalla, Kathleen A Farley, et al.
Bioorganic & Medicinal Chemistry
|
April 8, 2020
Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1
Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Journal of Medicinal Chemistry
|
February 1, 2017
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans
Atli Thorarensen, Martin E Dowty, Mary Ellen Banker, et al.
Nature Communications
|
May 16, 2025
Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca<sup>2+</sup> dependent allosteric binding site
Leslie A Dakin, Li Xing, Justin Hall, et al.
ACS Chemical Biology
|
October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
Jean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Nature Communications
|
August 31, 2024
Structural basis for CCR6 modulation by allosteric antagonists
David Jonathan Wasilko, Brian S Gerstenberger, Kathleen A Farley, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of Clinical and Translational Science
|
September 29, 2023
Evaluation of an online research best practices training for community health workers and promotoras
Susan L Murphy, Gina M Jay, Elias M Samuels, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 23, 2008
2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitor
John I Trujillo, James R Kiefer, Wei Huang, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2023
Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonists
Mark E Schnute, John I Trujillo, Katherine L Lee, et al.
Journal of Medicinal Chemistry
|
November 14, 2018
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors
Agustin Casimiro-Garcia, John I Trujillo, Felix Vajdos, et al.
Journal of Medicinal Chemistry
|
February 17, 2025
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists
Brian S Gerstenberger, Ray Unwalla, Kathleen A Farley, et al.
Bioorganic & Medicinal Chemistry
|
April 8, 2020
Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1
Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Journal of Medicinal Chemistry
|
February 1, 2017
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans
Atli Thorarensen, Martin E Dowty, Mary Ellen Banker, et al.
Nature Communications
|
May 16, 2025
Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca<sup>2+</sup> dependent allosteric binding site
Leslie A Dakin, Li Xing, Justin Hall, et al.
ACS Chemical Biology
|
October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
Jean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Nature Communications
|
August 31, 2024
Structural basis for CCR6 modulation by allosteric antagonists
David Jonathan Wasilko, Brian S Gerstenberger, Kathleen A Farley, et al.
Page
of 6